This study will assess safety and efficacy of the MED-EL BONEBRIDGE Bone Conduction Implant in children under 12 years old with conductive or mixed hearing loss.
This study will assess safety and efficacy of the MED-EL BONEBRIDGE Bone Conduction Implant in children under 12 years old with conductive or mixed hearing loss.
Expanded Indications in the Pediatric BONEBRIDGE Population
-
University of Colorado Health/Children's Hospital of Colorado, Aurora, Colorado, United States, 80045
University of Miami, Miami, Florida, United States, 33136
University Hospital Newark/Rutgers New Jersey Medical School, Newark, New Jersey, United States, 07103
University of North Carolina, Chapel Hill, North Carolina, United States, 27517
The Ohio State University/Nationwide Children's Hospital, Columbus, Ohio, United States, 43210
University of Utah Health/Primary Children's Hospital, Salt Lake City, Utah, United States, 84132
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
3 Years to 12 Years
ALL
No
Med-El Corporation,
2025-08